Hormonal contraception and HIV risk: evaluating marginal-structural-model assumptions

Epidemiology. 2011 Nov;22(6):877-8. doi: 10.1097/EDE.0b013e3182319910.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Contraceptive Agents, Female / adverse effects*
  • Contraceptives, Oral, Hormonal / adverse effects*
  • Data Interpretation, Statistical
  • Delayed-Action Preparations
  • HIV Infections / epidemiology*
  • HIV Infections / etiology
  • Humans
  • Medroxyprogesterone Acetate / adverse effects*
  • Models, Statistical
  • Risk Factors

Substances

  • Contraceptive Agents, Female
  • Contraceptives, Oral, Hormonal
  • Delayed-Action Preparations
  • Medroxyprogesterone Acetate